Number of the records: 1
imunokonjugáty
SYS d018796 LBL 00000cz--a2200000n--4500 005 20250606215435.0 008 940523|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 $d BA006 $d BA006 065 $a D12.776.124.790.651.114.580 065 $a D12.776.377.715.548.114.580 065 $a D27.505.696.477.266 066 $a 01 $c 03 150 $a imunokonjugáty $x AD $x AE $x AN $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x TO $x TU $x UL $x UR $2 slo 450 $w v $a Antibody Drug Conjugate $2 eng 450 $w v $a Antibody-Drug Conjugate $2 eng 450 $w v $a Radioimmunoconjugates $2 eng 450 $w v $a konjugát protilátka-liek $2 slo 450 $w v $a konjugát protilátky s liekom $2 slo 450 $w v $a konjugáty protilátka-liek $2 slo 450 $w v $a imunokonjugát $2 slo 450 $w v $a rádioimunokonjugát $2 slo 450 $w v $a rádioimunokonjugáty $2 slo 550 $7 sllk_us_auth*d058990 $Y Molecular Targeted Therapy $w b $a terapia molekulárne cielená 665 $a 95 $2 eng 665 $a Immunotoxins (1987-1994) $2 eng 680 9-
$i Combinations of diagnostic or therapeutic substances linked with specific immune substances such as IMMUNOGLOBULINS; MONOCLONAL ANTIBODIES; or ANTIGENS. Often the diagnostic or therapeutic substance is a radionuclide. These conjugates are useful tools for specific targeting of DRUGS and RADIOISOTOPES in the CHEMOTHERAPY and RADIOIMMUNOTHERAPY of certain cancers. $2 eng 750 -2
$a Immunoconjugates $2 eng 980 $x M
Number of the records: 1